Quent Capital’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$46.6K Buy
696
+16
+2% +$1.17K ﹤0.01% 830
2026
Q1
$51.9K Buy
680
+8
+1% +$577 ﹤0.01% 722
2025
Q4
$42.9K Sell
672
-154
-19% -$9.49K ﹤0.01% 788
2025
Q3
$52.1K Buy
+826
New +$57.7K ﹤0.01% 595
2025
Q2
Sell
-861
Closed -$75.9K 570
2025
Q1
$75.9K Sell
861
-256
-23% -$24.2K 0.01% 467
2024
Q4
$102K Buy
1,117
+419
+60% +$43K 0.01% 403
2024
Q3
$78.2K Hold
698
0.01% 564
2024
Q2
$68.4K Hold
698
0.01% 574
2024
Q1
$70K Buy
698
+52
+8% +$4.57K 0.01% 585
2023
Q4
$58K Buy
646
+392
+154% +$31.2K 0.01% 588
2023
Q3
$19.5K Buy
254
+60
+31% +$4.98K ﹤0.01% 800
2023
Q2
$16.2K Hold
194
﹤0.01% 831
2023
Q1
$16.4K Hold
194
﹤0.01% 819
2022
Q4
$15.8K Hold
194
﹤0.01% 813
2022
Q3
$14K Hold
194
﹤0.01% 802
2022
Q2
$17K Hold
194
﹤0.01% 738
2022
Q1
$22K Sell
194
-1,500
-89% -$176K ﹤0.01% 767
2021
Q4
$205K Buy
+1,694
New +$188K 0.04% 287

Other funds holding EMN

Quent Capital's EMN Position: Q2 2026 in Review

Quent Capital increased its Eastman Chemical (EMN) stake by 2.4% in Q2 2026, buying an estimated $1.17K and bringing the position to 696 shares worth $46.6K. The position accounts for ﹤0.01% of the portfolio, ranked #830.

Quent Capital first reported a position in EMN in Q4 2021 and has held it in 18 quarters since. The position peaked at $205K in Q4 2021. 642 funds tracked by Wall St. Rank hold EMN as of Q2 2026.

  • Quent Capital held 696 shares of Eastman Chemical worth $46.6K as of Q2 2026.
  • Quent Capital bought 16 Eastman Chemical shares in Q2 2026, an estimated $1.17K.
  • Eastman Chemical made up ﹤0.01% of Quent Capital's portfolio in Q2 2026, its #830 holding.
  • Quent Capital first reported a position in Eastman Chemical in Q4 2021 and has held it in 18 quarters since.
  • Quent Capital's Eastman Chemical position peaked at $205K in Q4 2021.
  • 642 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2026.

Based on Quent Capital's 13F filing for Q2 2026, filed 7 Aug 2026.